Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cadence Pharmaceuticals, Inc.
Cadence Pharmaceuticals Completes $86.6 Million Private Placement of Common Stock
March 8th, 2009
Cadence Pharmaceuticals, Inc. (NASDAQ:CADX) announced that it completed its previously announced private placement of approximately 12 million shares of the Company's common stock at a price of $7.13 per share and five-year warrants to purchase up to approximately 6 million additional shares of the Company's common stock, exercisable in cash or by net exercise at a price of $7.84 per share, for aggregate gross proceeds of approximately $86.6 million. The price paid for the common stock is equal to the consolidated closing bid price on the Nasdaq Global Market on the day of pricing, February 13, 2009. The financing was led by Venrock with participation by Frazier...
Source: Pharma Investments, Ventures & Law Weekly (2009-03-08)
|
